Apieron, Inc. is a medical device company committed to collaborating with physicians and patients to develop innovative medical solutions to improve quality of life and standards of care for people living with asthma. We are a private, venture-backed company based in Menlo Park, California. Apieron was formed in early 2001 to develop a non-invasive monitor to measure exhaled nitric oxide (eNO) for the management of asthma.
Apieron was co-founded by Bhairavi Parikh, a scientist and mother who wanted to develop an innovative approach for measuring eNO in an effort to provide an accurate, reliable and simple-to-use device for her family. Apieron’s core technology, a biosensor, utilizes a patented design that reliably detects eNO in a single human breath. This technology creates a system which is very sensitive to nitric oxide, enabling the accurate measurement of trace amounts of the gas (in parts per billion) using a non-invasive and safe technique. We are very excited to bring such a breakthrough innovation to physicians and their patients.
There is strong clinical evidence that suggests that asthma management and control can be significantly improved by regularly monitoring airway inflammation. Until now, the degree of inflammation has not been measurable in a simple and practical way. Measurement of eNO has been shown to optimize medication therapy and improve compliance among patients with asthma. We believe medication therapy should be tailored to each individual. Generalized treatment regimens that are targeted at segments of individuals may deliver less precise and less effective therapy. Periodic measurement of eNO, in conjunction with the physician’s usual standard of care, provides a more comprehensive method to manage asthma efficiently and effectively.